Produkty 1961358-01-9

CAS 1961358-01-9 występuje w naszej ofercie pod nazwami: (Z)-6-((10S,13R,14R,15S,17R)-15-Hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxohept-5-enoic acid, ≥95%, ≥95%, 15a-Hydroxy-3,11,23-trioxo-lanost-8,20-dien-26-oic acid, 97.78%. Oferty producentów: Chemat, MedChemExpress. Dostępne opakowania: 5mg, 1 mg.

(Z)-6-((10S,13R,14R,15S,17R)-15-Hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxohept-5-enoic acid, ≥95%, ≥95%
Chemat
  • opakowanie: 5mg
  • Warianty: 1
od 2282,00
Zobacz produkt
15a-Hydroxy-3,11,23-trioxo-lanost-8,20-dien-26-oic acid, 97.78%
MedChemExpress
  • opakowanie: 1 mg
  • Warianty: 1
od 1104,53
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(Z)-6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid (CAS 1961358-01-9) to związek chemiczny o wzorze sumarycznym C30H42O6 i masie molowej 498.6 g/mol. Nazwa systematyczna IUPAC: (Z)-6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid. InChIKey: GCIVDMXLMRSHLO-VITWSGEVSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H42O6
Masa molowa498.6 g/mol
Nazwa IUPAC(Z)-6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid
InChIKeyGCIVDMXLMRSHLO-VITWSGEVSA-N
SMILESCC(CC(=O)/C=C(/C)\[C@H]1C[C@@H]([C@@]2([C@@]1(CC(=O)C3=C2CC[C@@H]4[C@@]3(CCC(=O)C4(C)C)C)C)C)O)C(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 15a-Hydroxy-3,11,23-trioxo-lanost-8,20-dien-26-oic acid, orb1984675, Lanosta-8,20(22)-dien-26-oicacid,15-hydroxy-3,11,23-trioxo-,(15|A,20Z)-
Powiązane formy tego związku
6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid C30H42O6
Izomery (ten sam wzór sumaryczny)
[(1R,3Z,5R,7S,9R,10Z,12S,13S,14R)-1-acetyloxy-13-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-9-tricyclo[10.3.0.05,7]pentadeca-3,10-dienyl] (2E,4Z)-octa-2,4-dienoate C30H42O6
[(1S,4S,5S,6R,9S,10R,12R,14R)-5,6-dihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxo-4-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl] (2E,4Z)-deca-2,4-dienoate C30H42O6
[(1S,4S,5S,6R,9S,10R,12R,14R)-5,6-dihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxo-4-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl] (2E,4E)-deca-2,4-dienoate C30H42O6
(1S,2S,4R,6S,9S,10R,11R,14R,15R)-17-hydroxy-6-(2-hydroxypropan-2-yl)-2,9,11,14,19,19-hexamethyl-5-oxapentacyclo[12.8.0.02,11.04,10.015,20]docosa-16,20-diene-8,13,18-trione C30H42O6
(1S,2R,6S,7S,9R,11S,12S,15R,16S)-6-methoxy-15-[(1S)-1-[(2R)-5-(methoxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one C30H42O6
(E,6R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid C30H42O6